| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |